A double-blind, controlled trial to evaluate the efficacy and safety of vitamin K1 ointment for cetuximab and Panitumumab-induced acneiform eruptio
Phase 2
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000008099
- Lead Sponsor
- ational Cancer Center Hospital Pharmacy division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Currently treated with vitamin K analog or antagonist 2.Pregnancy or brestfeeding 3.Not eligible judged by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method